Research and Clinical Trials

Meet the investigator: Yi Lin, M.D., Ph.D.

By Nicole Ferrara • March 19, 2019
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic in Rochester, Minnesota, talks about her cellular therapy research.

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer cellular therapy research Research and Clinical Trials
Subscribe
Request an Appointment
Find a Clinical Trial
Clinical trials: A significant part of cancer care featured image
Clinical trials: A significant part of cancer care

Mayo Clinic doctors discuss the role clinical trials — research studies that test new treatments and other interventions — play in cancer care.

Photo of a man looking up at the sky, with the green leaves and branches of a large tree behind him.
Mayo Clinic researchers identify a measurable genetic mutation as a significant predictor of metastasis and survival in pancreatic cancer

The presence of a specific genetic mutation — KRAS circulating tumor DNA (ctDNA) — strongly indicates a higher risk of spread and worse survival rates for people with pancreatic cancer.

Photo of an older woman seated under a tree in a park.
Mayo Clinic researchers identify proteins linked to immunotherapy resistance in metastatic colorectal cancer

The team identified specific proteins — fibronectin and smooth muscle actin — associated with resistance to immunotherapy treatment in colorectal cancer tissues.